申请人:Gilead Sciences, Inc.
公开号:US20150080370A1
公开(公告)日:2015-03-19
The present disclosure relates to compounds that are sodium channel inhibitors and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In particular embodiments, the structure of the compounds is given by Formula I:
wherein R
1
, R
2
, R
3
, R
4
, and R
5
are as described herein, to methods for the preparation and use of the compounds and to pharmaceutical compositions containing the same.
本公开涉及的化合物是钠通道抑制剂,用于治疗各种疾病状态,包括心血管疾病和糖尿病。在特定实施例中,化合物的结构由公式I给出:其中R1,R2,R3,R4和R5如本文所述,涉及该化合物的制备和使用方法以及包含该化合物的制药组合物。